Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Various treatments help hair growth, but more research needed for safety and effectiveness.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Some off-label treatments increase hair density, but long-term safety unknown.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

PRP therapy can regrow 30%-40% of lost hair in 3 months without side effects.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

More personalized and effective treatments for androgenetic alopecia are needed.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

The summit aimed to speed up finding treatments for alopecia areata.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.